|
1
|
Schadler ED, Ortel B and Mehlis SL:
Biologics for the primary care physician: Review and treatment of
psoriasis. Dis Mon. 65:51–90. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Căruntu C, Boda D, Căruntu A, Rotaru M,
Baderca F and Zurac S: In vivo imaging techniques for psoriatic
lesions. Rom J Morphol Embryol. 55 (Suppl):1191–1196.
2014.PubMed/NCBI
|
|
3
|
Batani A, Brănișteanu DE, Ilie MA, Boda D,
Ianosi S, Ianosi G and Căruntu C: Assessment of dermal papillary
and microvascular parameters in psoriasis vulgaris using in
vivo reflectance confocal microscopy. Exp Ther Med.
15:1241–1246. 2018.PubMed/NCBI
|
|
4
|
Negrei C, Ginghină O, Căruntu C, Burcea
Dragomiroiu GTA, Jinescu G and Boda D: Investigation relevance of
methotrexate polyglutamates in biological systems by high
performance liquid chromatography. Rev Chim. 66:766–768. 2015.
|
|
5
|
Negrei C, Arsene AL, Toderașcu CD, Boda D
and Ilie M: Acitretin treatment in psoriasis may influence the cell
membrane fluidity. Farmacia. 60:767–771. 2012.
|
|
6
|
Negrei C, Căruntu C, Ginghina O,
Dragomiroiu GTAB, Toderascu CD and Boda D: Qualitative and
quantitative determination of methotrexate polyglutamates in
erythrocytes by high performance liquid chromatography. Rev Chim.
66:607–610. 2015.
|
|
7
|
Sbidian E, Chaimani A, Garcia-Doval I, Do
G, Hua C, Mazaud C, Droitcourt C, Hughes C, Ingram JR, Naldi L, et
al: Systemic pharmacological treatments for chronic plaque
psoriasis: A network meta-analysis. Cochrane Database Syst Rev.
12:CD0115352017.PubMed/NCBI
|
|
8
|
Olteanu R, Zota A and Constantin M:
Biosimilars: An update on clinical trials (review of published and
ongoing studies. Acta Dermatovenerol Croat. 25:57–66.
2017.PubMed/NCBI
|
|
9
|
Olteanu R, Constantin MM, Zota A,
Dorobantu DM, Constantin T, Serban ED, Balanescu P, Mihele D and
Gheuca-Solovastru L: Original clinical experience and approach to
treatment study with interleukine 12/23 inhibitor in
moderate-to-severe psoriasis patients. Farmacia. 64:918–921.
2016.
|
|
10
|
Zambrano R, Duitama JF, Posda JI and
Flórez JF: Perception of adherence to treatment among patients with
cardiovascular risk factors. Rev Fac Nac Salud Publica. 30:163–174.
2012.
|
|
11
|
Tatu AL and Nwabudike LC:
Metoprolol-associated onset of psoriatic arthropathy. Am J Ther.
24:e370–e371. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sabate E: Adherence to Long-Term
Therapies: Evidence for ActionWorld Health Organization; Geneva:
2003, https://www.who.int/chp/knowledge/publications/adherence_report/en/
|
|
13
|
Boda D, Negrei C, Nicolescu F and Balalau
C: Assessment of some oxidative stress parameters in methotrexate
treated psoriasis patients. Farmacia. 62:704–710. 2014.
|
|
14
|
Radtke MA and Augustin M: Economic
considerations in psoriasis management. Clin Dermatol. 26:424–431.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ross C, Marshman G, Grillo M and Stanford
T: Biological therapies for psoriasis: Adherence and outcome
analysis from a clinical perspective. Australas J Dermatol.
57:137–140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Raval K, Lofland JH, Waters H and Piech
CT: Disease and treatment burden of psoriasis: Examining the impact
of biologics. J Drugs Dermatol. 10:189–196. 2011.PubMed/NCBI
|
|
17
|
Schaarschmidt ML, Kromer C, Herr R,
Schmieder A, Goerdt S and Peitsch WK: Treatment satisfaction of
patients with psoriasis. Acta Derm Venereol. 95:572–578. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zschocke I, Ortland C and Reich K:
Evaluation of adherence predictors for the treatment of moderate to
severe psoriasis with biologics: The importance of
physician-patient interaction and communication. J Eur Acad
Dermatol Venereol. 31:1014–1020. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Doshi JA, Takeshita J, Pinto L, Li P, Yu
X, Rao P, Viswanathan HN and Gelfand JM: Biologic therapy
adherence, discontinuation, switching, and restarting among
patients with psoriasis in the US Medicare population. J Am Acad
Dermatol. 74:1057–1065.e4. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Umezawa Y, Nobeyama Y, Hayashi M, Fukuchi
O, Ito T, Saeki H and Nakagawa H: Drug survival rates in patients
with psoriasis after treatment with biologics. J Dermatol.
40:1008–1013. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gniadecki R, Kragballe K, Dam TN and Skov
L: Comparison of drug survival rates for adalimumab, etanercept and
infliximab in patients with psoriasis vulgaris. Br J Dermatol.
164:1091–1096. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim WB, Marinas JE, Qiang J, Shahbaz A,
Greaves S and Yeung J: Adverse events resulting in withdrawal of
biologic therapy for psoriasis in real-world clinical practice: A
Canadian multicenter retrospective study. J Am Acad Dermatol.
73:237–241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kaushik SB and Lebwohl MG: Psoriasis:
Which therapy for which patient: Focus on special populations and
chronic infections. J Am Acad Dermatol. 80:43–53. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martín B, Sánchez-Carazo JL,
Pérez-Ferriols A, Laguna C, Oliver V and Alegre V: Clinical
experience with etanercept in the treatment of psoriasis. Actas
Dermosifiliogr. 99:540–545. 2008.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sehgal VN, Pandhi D and Khurana A:
Biologics in dermatology: An integrated review. Indian J Dermatol.
59:425–441. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Niculet E, Neculia GV, Tatu AL and Buzia
OD: Curcumin-extraction, physical and chemical analysis, formulas
and control. Basic methods for further research. Mater Plast.
55:672–675. 2018.
|
|
27
|
Nwabudike LC and Tatu AL: Using
complementary and alternative medicine for the treatment of
psoriasis: A step in the right direction. JAMA Dermatol.
155:6362019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Căruntu C, Boda D, Dumitrașcu G,
Constantin C and Neagu M: Proteomics focusing on immune markers in
psoriatic arthritis. Biomarkers Med. 9:513–528. 2015. View Article : Google Scholar
|
|
29
|
Ilie MA, Căruntu C, Lixandru D, Tampa M,
Georgescu SR, Constantin MM, Constantin C, Neagu M, Zurac SA and
Boda D: In vivo confocal laser scanning microscopy imaging
of skin inflammation: Clinical applications and research
directions. Exp Ther Med. 17:1004–1011. 2019.PubMed/NCBI
|
|
30
|
Căruntu C, Boda D, Musat S, Căruntu A and
Mandache E: Stress-induced mast cell activation in glabrous and
hairy skin. Mediators Inflamm. 2014:1059502014. View Article : Google Scholar : PubMed/NCBI
|
